| LOS ≤ 1 day (n = 562) | LOS > 1 day (n = 579) | p | ||
---|---|---|---|---|---|
Revision TAA | 8.7% | (49/562) | 9.8% | (57/579) | 0.513 |
Sex | |||||
 Male | 58.4% | (328/562) | 45.1% | (261/579) | < 0.001* |
 Female | 41.6% | (234/562) | 54.9% | (318/579) |  |
Race/ethnicity | |||||
 Asian | 0.9% | (5/562) | 0.3% | (2/579) | 0.281 |
 Black or African American | 2.1% | (12/562) | 3.6% | (21/579) | 0.133 |
 Hispanic | 2.7% | (15/562) | 2.9% | (17/579) | 0.785 |
 White | 83.8% | (471/562) | 65.8% | (381/579) | < 0.001* |
 Other | 0.4% | (2/562) | 0.3% | (2/579) | > 0.999 |
Unknown/not reported | 10.1% | (57/562) | 26.9% | (156/579) | < 0.001* |
Age (years) | |||||
 Under 50 | 8.0% | (45/562) | 7.9% | (46/579) | 0.969 |
 Between 50 and 59 | 26.0% | (146/562) | 20.9% | (121/579) | 0.043* |
 Between 60 and 69 | 38.8% | (218/562) | 38.5% | (223/579) | 0.924 |
 Between 70 and 79 | 23.8% | (134/562) | 26.8% | (155/579) | 0.256 |
 80 and over | 3.4% | (19/562) | 5.9% | (34/579) | 0.046* |
BMI (kg/m2) | |||||
 Underweight | 0.5% | (3/562) | 1.0% | (6/579) | 0.507 |
 Normal | 11.9% | (67/562) | 14.9% | (86/579) | 0.146 |
 Overweight | 39.1% | (220/562) | 31.8% | (184/579) | 0.009* |
 Obese class I | 26.9% | (151/562) | 28.2% | (163/579) | 0.627 |
 Obese class II | 14.6% | (82/562) | 16.9% | (98/579) | 0.279 |
 Obese class III | 6.9% | (39/562) | 7.3% | (42/579) | 0.836 |
Comorbidities | |||||
 Diabetes | 10.5% | (59/562) | 14.3% | (83/579) | 0.050* |
 Smoker | 10.0% | (56/562) | 6.2% | (36/579) | 0.020* |
 COPD | 2.3% | (13/562) | 2.4% | (14/579) | 0.907 |
 Congestive heart failure | 0.2% | (1/562) | 0.2% | (1/579) | > 0.999 |
 Hypertension | 55.0% | (309/562) | 56.1% | (325/579) | 0.696 |
 Dialysis | 0.0% | (0/562) | 0.3% | (2/579) | 0.500 |
 Chronic steroid use | 4.1% | (23/562) | 6.0% | (35/579) | 0.133 |
ASA class | |||||
 Class 1 (no disturbance) | 6.0% | (34/562) | 3.4% | (20/579) | 0.039* |
 Class 2 (mild disturbance) | 60.5% | (340/562) | 51.6% | (299/579) | 0.003* |
 Class 3 (severe disturbance) | 32.2% | (181/562) | 43.4% | (251/579) | < 0.001* |
 Class 4+ (life threatening) | 1.3% | (7/562) | 1.6% | (9/579) | 0.657 |